Eyenovia News News Announcement Ratings Eyenovia Regains Compliance With All Nasdaq Continued Listing Requirements GlobeNewswireFeb 26 20:00 Eyenovia Allows Full Debt Conversion to Common Shares at $1.68 Starting April 2025, Defers Payments Until September 2025 BenzingaFeb 24 20:08 Express News | ...
Eyenovia允许自2025年4月起以1.68美元完全转换为普通股,并推迟至2025年9月付款。 Eyenovia, Inc. (纳斯达克:EYEN) ("Eyenovia" 或 "公司"), 一家专注于完成其专有Optejet设备开发的眼科科技公司, 今天宣布它已进入 Benzinga02/24 20:08 快讯| Eyenovia公司宣布债务重组,包括对高级担保债务的修订,改善现金流以便...
What a great day we had today with the news from $TXNP! Every advancement we see will be very beneficial for everyone, both as users and clients. $VTGN $EYEN Bullish Advertisement. Remove ads. braves19831:13 AM $EYEN the only thing green is this piece of shit Top Posts eWhispers #ea...
News Transcripts & Insights SEC Filings Press Releases Related AnalysisEYEN Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -98.58% Eyenovia, Inc. price and volume Combination chart with 2 data series. Chart represents Eyenovia, Inc. price and volume over 1Y period The chart...
Company announces results from a Phase IV study of Mydcombi designed to characterize the efficacy and duration of the lowest deliverable dose (one 8µL...
周四,H.C. Wainwright维持对Eyenovia (NASDAQ:EYEN)股票的中性立场,重申2.00美元的目标价。该公司分析师Matthew Caufield强调了美国食品和药物管理局(FDA)批准Eyenovia的Optejet眼科喷雾设备用于Mydcombi,这是一种用于药物性散瞳(即为眼科检查和手术而进行的瞳孔扩张)的固定剂量组合喷雾。根据InvestingPro分析,尽管Eyenovia...
Eyenovia and Senju will meet with the FDA to present a clinical development proposal for a combination drug-dispensing device product for chronic dry eye disease.Image: Adobe Stock “We believe this product, if approved, has the potential to be used together with other therapies to better addre...
More News January 23, 2025 NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal December 19, 2024 NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders Decem...
Discover real-time Eyenovia, Inc. Common Stock (EYEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Eyenovia, lantech making strides in microdosing and cataract marketsLinnehan, RobertOcular Surgery News